InsidersTradesSigma
Follow the Interpace Diagnostics Group, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €39.9m. The latest transaction was reported on 5 February 2016 (Attribution). Among the most active insiders: Glorikian Harry. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Interpace Diagnostics Group, Inc. is a company focused on the development and commercialization of diagnostic tests for cancer. It aims to improve patient outcomes through genomic-based solutions.